Study examines telephone intervention in glaucoma treatment adherence

A telephone intervention trial was associated with improvement in glaucoma medication adherence in both the treatment group and the control group but, when the two groups were compared, interactive telephone calls and tailored print materials did not significantly improve adherence, according to a report of a randomized controlled clinical trial published Online First by Archives of Ophthalmology.

Glaucoma affects more than 2 million adults over the age of 40 in the United States. While medication can reduce the visual field loss caused by this , nonadherence by patients to their medication regimen is a treatment challenge and regular follow-up medical appointments are crucial, according to the study background.

Karen Glanz, Ph.D., M.P.H., of the University of Pennsylvania, Philadelphia, and colleagues enrolled 312 patients with glaucoma in a at two eye clinics at a Veterans Affairs hospital and a large public hospital. The patients (average age nearly 63 years) were considered to be nonadherent because they did not take their medication, refill their medicine and/or keep their medical appointments.

Patients were divided into either the treatment or . The treatment group received automated, interactive telephone calls and tailored printed materials, while the control group received usual care, which included the recommendation for medical appointments and medication refills. Researchers measured adherence to medication taking, prescription refills and appointment keeping based on interviews, medical charts and other data.

"A statistically significant increase for all adherence measures was noted in both the treatment group and the control group in the I-SIGHT (Interactive Study to Increase Glaucoma Adherence to Treatment) trial. The treatment group had greater improvements in adherence in 4 of 6 categories, but this did not reach statistical significance," the authors comment.

Researchers suggest that "motivated patients" in an ongoing clinical trial might improve their adherence even without tailored messages for encouragement.

"New technologies, such as interactive voice recognition and electronic reminder devices, may play a supportive role in the effort to improve in patients with glaucoma, but further study is warranted," the authors conclude.

More information: Arch Ophthalmol. Published online June 11, 2012. doi:10.1001/archophthalmol.2012.1607

Related Stories

Study: Getting patients to take their asthma meds

date Jun 15, 2010

Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks, according to researchers at Henry Ford Hospital in Detroit.

Recommended for you

Miniature pump regulates internal ocular pressure

date Jul 01, 2015

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, Fraunhofer researchers are developing ...

Closing the Australian eye health gap may be in sight

date Jun 30, 2015

Three years after the launch of the roadmap to close the gap for vision, progress has been made but "much remains to be done", according to the authors of a Perspective published online today by the Medical Jo ...

Pioneering gene therapy takes aim at inherited blindness

date Jun 29, 2015

Canada's first human gene therapy trial for eyes—the replacement of a faulty gene with a healthy one—is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people ...

Iris research focuses on blood vessel patterns

date Jun 29, 2015

The structure of the microvasculature or blood vessels in the iris could play an important role in people's contraction of eye maladies like glaucoma and cataract, according to a WA-led study.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.